| Filed On | Filing |
|---|---|
| 22 Nov 2016 |
8-K/A: Financial Statements and Exhibits
The accompanying unaudited pro forma condensed combined financial statements of Fortress Biotech, Inc. (“Fortress”, “FBIO” or the “Company”) are presented to illustrate the estimated effects of the acquisition of a majority equity stake ... |
| 26 Feb 2014 |
8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation +1 more
This RESTRICTED STOCK ISSUANCE AGREEMENT (the “Agreement”) is made and entered into as of February 20, 2014, by and between Coronado Biosciences Inc., a Delaware corporation (the “Company”), and Michael S. Weiss (the “Grantee”). |
Loading...